Organizing pneumonia and COVID-19

Am J Med Sci. 2023 Dec;366(6):458-463. doi: 10.1016/j.amjms.2023.09.023. Epub 2023 Sep 30.

Abstract

Organizing pneumonia (OP) is an interstitial lung disease, and can be cryptogenic, if no cause is identified, or secondary to several conditions. COVID-19-induced persistent inflammation can be associated with interstitial lung disease. We present a review of literature of OP and COVID-19-induced OP with an illustrative case. A 38-year-old man was admitted with COVID-19 that required mechanical ventilation for 56 days. Initial chest computed tomography (CT) revealed diffuse bilateral ground-glass opacities in the lungs with consolidation areas involving 75 % of the parenchyma. After weaning from MV, the patient still required oxygen supplementation. A new chest CT scan also showed extensive diffuse areas of consolidation and ground-glass opacity. OP was hypothesized and 40 mg/day prednisone initiated and continued for six months with resolution of lung functional and image abnormalities. Organizing pneumonia should be included in the differential diagnosis of COVID-19 patients with respiratory symptoms after partial pulmonary recovery.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • COVID-19* / complications
  • Humans
  • Lung / diagnostic imaging
  • Lung Diseases, Interstitial* / complications
  • Male
  • Organizing Pneumonia*
  • Pneumonia*